Variable | Overall (n = 332) | Group 1 (n = 148) | Group 2 (n = 111) | Group 3 (n = 73) | P value |
---|---|---|---|---|---|
CAD severity, n (%) | < 0.001 | ||||
One-vessel disease | 72 (21.8) | 50 (33.8) | 19 (17.3) * | 3 (4.1) *§ | |
Two-vessel disease | 107 (32.3) | 52 (35.1) | 34 (30.9) | 21 (28.8) | |
Three-vessel or LM disease | 152 (45.9) | 46 (31.1) | 57 (51.8) * | 49 (67.1) * | |
Culprit vessel, n (%) | 0.033 | ||||
LM | 1 (0.3) | 0 (0) | 0 (0) | 1 (1.4) | |
LAD | 176 (53.2) | 84 (56.8) | 61 (55.5) | 31 (42.5) | |
LCX | 43 (13.0) | 25 (16.9) | 10 (9.1) | 8 (11.0) | |
RCA | 111 (33.5) | 39 (26.4) | 39 (35.4) * | 33 (45.2) * | |
TIMI flow 0 | 216 (65.5) | 102 (68.9) | 72 (65.5) | 42 (58.3) | 0.30 |
Collateral circulation | 78 (24.9) | 37 (26.6) | 25 (23.4) | 16 (22.9) | 0.78 |
Proximal lesion | 115 (35.0) | 46 (31.3) | 43 (39.1) | 26 (36.1) | 0.42 |
Median follow-up time, months | 69.8 ± 29.3 | 76.3 ± 28.8 | 68.1 ± 29.3 | 59.4 ± 27.4 | < 0.001 |